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Abstract 4,5-Diaminofluorescein (DAF-2) and its membrane-
permeable derivate DAF-2 diacetate are fluorescent probes that
have been developed to perform real-time biological detection of
nitric oxide (NO). Their use for intracellular imaging, however,
has recently been seriously questioned and data using DAF-2 for
extracellular NO detection at low levels, as for example released
from endothelial cells, are rare. Here we show that a reliable
detection of low levels of NO in biological systems by DAF-2 is
possible (a) by using low DAF-2 concentrations (0.1 WM) and (b)
by subtracting the DAF-2 auto-fluorescence from the measured
total fluorescence. The described method allows easy real-time
detection of endothelial NO formation. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Nitric oxide (NO) is an arginine-derived radical playing a
pivotal role in numerous physiologic as well as pathophysio-
logic processes. The molecule is being implicated in neuro-
transmission, immune function, hemostasis and vascular
tone as well as in pathologic conditions as septic shock, athe-
rosclerosis, ischemia/reperfusion injury, and carcinogenesis [1^
3]. Reliable detection and quanti¢cation of NO is therefore a
subject of signi¢cant biomedical interest.
NO is synthesized by NO synthases (NOS). These enzymes
are either constitutively expressed (cNOS) synthesizing low
levels of NO in the pico- to nanomolar range (NOS I, NOS
III) or are induced by, for example, cytokines producing NO
in the nano- to micromolar range (NOS II) [1]. The low cel-
lular output from cells expressing a cNOS, like endothelial
cells, and the short half-life of NO make its direct measure-
ment extremely di⁄cult.
Several methods have been developed over the past years to
detect NO [4]. None of these methods, however, has the sen-
sitivity, speci¢city and ease of use to be used routinely to
measure low-output NO in an average equipped laboratory.
Several years ago, Kojima et al. developed £uorescence probes
based on the £uorescein chromophore which are able to detect
intra- as well as extracellular NO [5^8]. The probe mostly used
up to now is 4,5-diamino£uorescein (DAF-2). DAF-2 which
itself shows only low £uorescence reacts with NO to the
highly £uorescent triazolo£uorescein (DAF-2T). DAF-2 is
membrane-impermeable. To measure intracellular NO cells
can be loaded with the membrane-permeable DAF-2 diacetate
(DAF-2 DA) which is hydrolyzed to DAF-2 and thus trapped
within the cell. DAF-2 DA was used in a number of studies
detecting intracellular NO mainly by £uorescence microscopy
and £ow cytometry [9^11]. The reliability of this method,
however, was recently seriously questioned by Broillet et al.
showing that, in the presence of NO, divalent cations like
Ca2 increase DAF-2 £uorescence [12]. The Ca2 sensitivity
of DAF-2, thus, makes it di⁄cult to distinguish an intracel-
lular Ca2 increase from an increase in intracellular NO. Mea-
surement of extracellular NO released from cells by DAF-2
should be less prone to this problem and thus might o¡er an
alternative to the intracellular bio-imaging by DAF-2 DA.
Using the published method employing 10 WM DAF-2 [5^8]
we were, however, unable to detect NO released from endo-
thelial EA.hy926 cells. In fact, searching the literature, we
found only two publications using DAF-2 or DAF-4 for
extracellular NO measurement released from endothelial cells
[7,13] implying that this method may be prone to error.
We, therefore, re-examined the use of DAF-2 for the extra-
cellular measurement of low-output NO using the human en-
dothelial cell line EA.hy926. We found that a reliable detec-
tion of low levels of NO in biological systems by DAF-2 is
possible (a) by using lower DAF-2 concentrations (0.1 WM)
and (b) by subtracting the DAF-2 auto-£uorescence from the
measured total £uorescence. With these changes in the han-
dling of DAF-2, we found this £uorescent probe indeed suit-
able to measure NO released from human endothelial cells.
2. Materials and methods
2.1. Chemicals
DAF-2, DAF-2T, the calcium ionophore A23187, NG-monomethyl-
L-arginine (L-NMMA) and the NO donor MAHMAWNONOate
(NOC-9) were purchased from Alexis0 Biochemicals (Gru«nberg, Ger-
many). L-Arginine hydrochloride and dimethyl sulfoxide were pur-
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chased from Sigma (Deisenhofen, Germany). Phorbol-12-myristate-
13-acetate (PMA) was purchased from Calbiochem (San Diego, CA,
USA). Phosphate-bu¡ered saline (PBS) contained 1.47 mM KH2PO4,
2.68 mM KCl, 137 mM NaCl, 0.90 mM CaCl2, 0.49 mM MgSO4 and
9.57 mM NaPO4 (pH 7.4).
2.2. Cell culture
The human endothelial cell line EA.hy926 (kindly provided by Dr.
Edgell, University of North Carolina, NC, USA) [14] were grown in
Dulbecco’s modi¢ed Eagle’s medium without phenol red containing
584 mg/l L-glutamine (BioWhittaker Europe, Belgium) supplemented
with 100 U/ml benzylpenicillin, 100 Wg/ml streptomycin (PAN Bio-
tech, Germany), HAT supplement (100 WM hypoxanthine/0.4 WM
aminopterin/16 WM thymidine) and 10% fetal bovine serum (LifeTech-
nologies, Germany). For experiments, cells were seeded in six-well
plates at a density of 0.4U106 cells/well. Assays were performed ex-
actly 4 days after seeding, when cells reached the state of con£uence,
to ensure equal cell growth conditions for all experiments [15]. As a
positive control, cells were stimulated with PMA (2 nM, 18 h) [16].
2.3. Spectro£uorimetric determination of NO released from
endothelial cells
Cells were washed with PBS and then pre-incubated with L-arginine
(100 WM in PBS, 5 min, 37‡C). In some experiments as indicated,
L-NMMA was added 5 min before the addition of L-arginine. Sub-
sequently, 1 WM A23187 and DAF-2 at various concentrations as
indicated were added and cells were incubated in the dark (37‡C,
5 min). Then the £uorescence of the supernatants was measured at
room temperature using a spectro£uorimeter (RF 1501, Shimadzu)
with excitation wavelength set at 495 nm and emission wavelength
at 515 nm. The band width was 10 nm for both excitation and emis-
sion. The sensitivity was programmed on high.
2.4. Data analysis
Analysis of data (column statistic, linear regression, statistical anal-
ysis) was performed using the software GraphPad PRISM0 (Graph-
Pad Software, Inc., San Diego, CA, USA).
3. Results and discussion
The measurement of NO by using the £uorescent probe
DAF-2 is based on the reaction of DAF-2 with NO in the
presence of O2 under neutral pH, yielding the highly £uores-
cent DAF-2T (Fig. 1) [7]. Since we were unable to detect NO
released from EA.hy926 endothelial cells using the published
method [5^8] the following considerations were made:
although DAF-2 and DAF-2T di¡er strongly in their £uores-
cence output, their absorbance as well as £uorescence maxima
are nearly identical [5,6]. Consequently, measurement of
DAF-2T includes a simultaneous detection of DAF-2. In
high-output NO systems the contribution of the DAF-2
auto-£uorescence to the measured total £uorescence may be
negligible due to the high quantum yield of DAF-2T, that is
more than 180 times higher than that of DAF-2 [6,7]. In
systems with a low output of NO, such as endothelial cells,
DAF-2 auto-£uorescence may, however, contribute consider-
ably to the measured total £uorescence. Thus, a small increase
in DAF-2T due to low levels of released NO may not be
detectable.
We addressed this hypothesis by measuring the auto-£uo-
rescence of various concentrations of DAF-2 in PBS in com-
parison to the £uorescence obtained from PBS supernatants
of A23187-activated EA.hy926 cells containing [DAF-2^
DAF-2T]. As expected, the di¡erence in £uorescence inten-
sities of DAF-2 in PBS and [DAF-2^DAF-2T] in supernatants
of EA.hy926 cells was hardly detectable at higher DAF-2
concentrations (1^5 WM). In contrast, at low DAF-2 concen-
trations (0.01^0.1 WM) the £uorescence of EA.hy926 super-
natants was signi¢cantly increased compared to DAF-2 in
PBS (data not shown). This result suggests that detection of
NO generated by endothelial cells demands low DAF-2 con-
centrations.
The use of low DAF-2 concentrations (e.g. 0.1 WM), how-
ever, raises the question whether this low amount is still su⁄-
cient to trap all NO released e.g. from endothelial cells. Con-
sidering the stoichiometry of the reaction between DAF-2 and
NO that is proposed to be 1:2 [7], 0.1 WM DAF-2 should be
consumed by 200 nM NO. Thus, if NO release reaches the
nanomolar range 0.1 WM DAF-2 is likely to be rate limiting
for the reaction.
In order to be able to calculate how much DAF-2 is exactly
consumed in our system (using 0.1 WM DAF-2 and EA.hy926
cells) we created a standard curve for the DAF-2T £uores-
cence intensity (slope: 59.09 þ 0.3609; y-intercept:
0.8170 þ 0.1664; r2 : 0.999) and a curve correlating increasing
amounts of NO (released from the NO donor NOC-9 in the
presence of EA.hy926 cells) to the £uorescence intensity ob-
tained after addition of 0.1 WM DAF-2. Fig. 2 shows that up
to 100 nM NOC-9 (corresponding to 200 nM NO [17]) the
correlation is linear (r2 = 0.997) suggesting that the reaction, in
spite of the above discussed stoichiometry, is not running out
of DAF-2. The reason for this becomes clear when the
amount of consumed DAF-2 is calculated by use of the
DAF-2T standard curve: the highest applied concentrationFig. 1. Structures of DAF-2 and DAF-2T.
Fig. 2. Dependency of the £uorescence intensity on the NO concen-
tration released from the NO donor NOC-9 using DAF-2 (0.1 WM).
Con£uent EA.hy926 cells were washed with PBS and incubated
with 100 WM L-arginine (5 min). Then 0.1 WM DAF-2 and NOC-9
at various concentrations as indicated were added. The cells were
incubated in the dark (37‡C, 5 min) and the £uorescence of the
supernatants was measured as described in Section 2. The £uores-
cence obtained from cells without NOC-9 addition was subtracted
from each value. All data are mean þ S.D. (n = 6).
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of NOC-9 (100 nM, corresponding to 200 nM NO) consumes
only 0.44 nM DAF-2. Thus, less than 1% of all employed
DAF-2 is converted in fact to DAF-2T.
Explanations for this ¢nding may be, ¢rst, that other com-
pounds, such as thiols, present in biological samples may react
with NO and its oxidation products and thus in£uence the
yield of DAF-2T [7]. Second, the mechanism of the reaction
between NO and DAF-2 is complex: DAF-2 does not react
with NO itself but with an active intermediate formed during
the oxidation of NO [7]. Thus, the reaction yield of DAF-2T
depends not only on the concentration of NO and DAF-2 but
also on the oxidation rate of NO.
Taken together, the above results demonstrated that detec-
tion of low amounts of NO demands low DAF-2 concentra-
tions and that a concentration of 0.1 WM DAF-2 is not rate
limiting for the reaction with NO in the nanomolar range.
Moreover, since we showed that less than 1% of DAF-2 is
converted to DAF-2T, the background £uorescence formed
by DAF-2 stays nearly constant (v99%) and thus can be
subtracted from the measured total £uorescence under the
conditions used in our system (0.1 WM DAF-2, 5 min incuba-
tion time, 37‡C). This will lead to a selective detection of
DAF-2T.
In order to test this newly developed DAF-2 method based
on (a) the use of low concentrations of DAF-2 (0.1 WM) and
(b) the subtraction of DAF-2 auto-£uorescence from the mea-
sured total £uorescence, we employed known NOS III activa-
tors and inhibitors. Fig. 3A shows the £uorescence intensities
of PBS supernatants in the absence or presence of the calcium
ionophore A23187 (1 WM) of untreated cells, cells which were
treated with the NOS III inductor PMA (2 nM, 18 h) [16] and
cells treated with PMA and the NOS III inhibitor L-NMMA
(1 WM). Addition of A23187, that increases intracellular free
Ca2 and thereby NOS III enzyme activity, increased £uores-
cence intensities in both untreated and PMA-activated cells.
Supernatants of PMA-activated cells showed considerably in-
creased £uorescence intensities compared to control cells in
the presence as well as in the absence of A23187. The NOS
III inhibitor L-NMMA reduced this £uorescence intensity sig-
ni¢cantly and dose dependently (Fig. 3B). These data demon-
strate that indeed physiological amounts of endothelial NO
can be detected using the method described here.
In summary, we optimized the use of the £uorescent probe
DAF-2 in order to allow reliable detection of extracellular
low-output NO from e.g. endothelial cells. Essential require-
ments for the detection of NO in the low-nM range were
found to be (a) the use of low DAF-2 concentrations
(0.1 WM) and (b) the subtraction of the DAF-2 auto-£uores-
cence from the measured total £uorescence. Our newly devel-
oped assay is simple, economical and sensitive and may there-
fore serve many laboratories as acceptable method for
detecting biological low-output NO.
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